{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:57:20Z","timestamp":1781585840943,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016806","name":"Natural Science Foundation of Nantong City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1704283"],"award-info":[{"award-number":["U1704283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["142300410057"],"award-info":[{"award-number":["142300410057"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejps.2021.106078","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:18:52Z","timestamp":1637720332000},"page":"106078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application"],"prefix":"10.1016","volume":"168","author":[{"given":"Jingjing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1081\/DDC-120016730","article-title":"Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine","volume":"29","author":"Aktas","year":"2003","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2021.106078_bib0002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2019.03.015","article-title":"Characterization of thymoquinone\/hydroxypropyl-beta-cyclodextrin inclusion complex: application to anti-allergy properties","volume":"133","author":"Al-Qubaisi","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106078_bib0003","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/IJN.S126199","article-title":"Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone","volume":"12","author":"Ban","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/jop.2007.0088","article-title":"Corneal permeation studies of everolimus microemulsion","volume":"24","author":"Baspinar","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.ejps.2021.106078_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201700261","article-title":"Hyaluronic acid-based micelles as ocular platform to modulate the loading, release, and corneal permeation of corticosteroids","volume":"17","author":"Bongiovi","year":"2017","journal-title":"Macromol. Biosci."},{"issue":"5","key":"10.1016\/j.ejps.2021.106078_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2710.2009.01095.x","article-title":"Solubilization of vorinostat by cyclodextrins","volume":"35","author":"Cai","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0007","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00407896","article-title":"Differences in hydration characteristics of corneas in various animal species. Histochemical study of acid mucopolysaccharides","volume":"190","author":"Cejkova","year":"1974","journal-title":"Albrecht Von Graefes Arch Klin Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0008","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1208\/pt060243","article-title":"Cyclodextrins in drug delivery: an updated review","volume":"6","author":"Challa","year":"2005","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0009","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.carbpol.2011.01.031","article-title":"Crassicauline A\/\u03b2-cyclodextrin host\u2013guest system: preparation, characterization, inclusion mode, solubilization and stability","volume":"84","author":"Chen","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejps.2021.106078_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2016.12.026","article-title":"Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers","volume":"99","author":"Chen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106078_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejpb.2021.02.012","article-title":"Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking","volume":"162","author":"Conde Penedo","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.ejps.2021.106078_bib0012","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1016\/j.bmc.2008.03.057","article-title":"Sulfadiazine\/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and molecular modeling","volume":"16","author":"de Araujo","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2021.106078_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120318","article-title":"In situ forming and mucoadhesive ophthalmic voriconazole\/HPbetaCD hydrogels for the treatment of fungal keratitis","volume":"597","author":"Diaz-Tome","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.106078_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111523","article-title":"Enhanced cellular uptake and cytotoxicity of vorinostat through encapsulation in TPGS-modified liposomes","volume":"199","author":"Farooq","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020149","article-title":"Development and characterization of a tacrolimus\/hydroxypropyl-beta-cyclodextrin eye drop","volume":"13","author":"Garcia-Otero","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0016","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0975-1483.104365","article-title":"Studies on the preparation, characterization, and solubility of 2-hp-beta-cyclodextrin-meclizine HCl inclusion complexes","volume":"4","author":"George","year":"2012","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.ejps.2021.106078_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exer.2015.09.010","article-title":"Development of a novel in vivo corneal fibrosis model in the dog","volume":"143","author":"Gronkiewicz","year":"2016","journal-title":"Exp. Eye. Res."},{"issue":"8","key":"10.1016\/j.ejps.2021.106078_bib0018","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/IIO.0b013e31829ceefa","article-title":"Corneal alkali burns: a review of the literature and proposed protocol for evaluation and treatment","volume":"53","author":"Hamill","year":"2013","journal-title":"Int. Ophthalmol. Clin."},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1208\/s12249-011-9639-5","article-title":"Enhanced solubility, stability, and transcorneal permeability of delta-8-tetrahydrocannabinol in the presence of cyclodextrins","volume":"12","author":"Hippalgaonkar","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0021","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.drudis.2015.11.017","article-title":"Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex","volume":"21","author":"Jambhekar","year":"2016","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.ejps.2021.106078_bib0022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lfs.2018.07.002","article-title":"Olopatadine enhances recovery of alkali-induced corneal injury in rats","volume":"207","author":"Kandeel","year":"2018","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0023","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/1567201043334623","article-title":"Role of cyclodextrins in ophthalmics","volume":"1","author":"Kaur","year":"2004","journal-title":"Curr. Drug. Deliv."},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0024","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1208\/s12249-017-0863-5","article-title":"Co-delivery of vorinostat and etoposide via disulfide cross-linked biodegradable polymeric nanogels: synthesis, characterization, biodegradation, and anticancer activity","volume":"19","author":"Kumar","year":"2018","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"7","key":"10.1016\/j.ejps.2021.106078_bib0025","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1166\/jnn.2021.19167","article-title":"Evaluation of Ibuprofen\/montmorillonite nano-clay composites as an oral drug delivery system and in-vitro drug release performance","volume":"21","author":"Kwon","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.ejps.2021.106078_bib0026","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/10717544.2018.1461278","article-title":"Fabrication of a drug delivery system that enhances antifungal drug corneal penetration","volume":"25","author":"Li","year":"2018","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.ejps.2021.106078_bib0027","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2014.05.020","article-title":"Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection","volume":"62","author":"Li","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106078_bib0028","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ijbiomac.2021.05.077","article-title":"Preparation and characterization of native and autoclaving-cooling treated Pinellia ternate starch and its impact on gut microbiota","volume":"182","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ejps.2021.106078_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/mp300445a","article-title":"Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model","volume":"10","author":"Li","year":"2013","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/nano10040709","article-title":"In Vitro and Ex Vivo evaluation of nepafenac-based cyclodextrin microparticles for treatment of eye inflammation","volume":"10","author":"Lorenzo-Veiga","year":"2020","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10408347008085634","article-title":"Phase solubility analysis","volume":"1","author":"Mader","year":"1970","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.ejps.2021.106078_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejps.2015.12.015","article-title":"Inclusion complexes of hydrochlorothiazide and beta-cyclodextrin: physicochemical characteristics, in vitro and in vivo studies","volume":"83","author":"Mendes","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.106078_bib0033","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2016.09.029","article-title":"Enhanced in vitro cytotoxicity and anti-tumor activity of vorinostat-loaded pluronic micelles with prolonged release and reduced hepatic and renal toxicities","volume":"96","author":"Mohamed","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejps.2021.106078_bib0034","first-page":"11","article-title":"Penetration enhancers in ocular drug delivery","author":"Moiseev","year":"2019","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/mp3005963","article-title":"Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability","volume":"10","author":"Morrison","year":"2013","journal-title":"Mol. Pharm."},{"issue":"07","key":"10.1016\/j.ejps.2021.106078_bib0036","doi-asserted-by":"crossref","DOI":"10.4172\/2153-2435.1000396","article-title":"Validation of a RP-HPLC method for the quantitation of vorinostat in rat plasma and its application to a pharmacokinetic study","volume":"06","author":"Mullangi","year":"2015","journal-title":"Pharm. Anal. Acta"},{"issue":"10","key":"10.1016\/j.ejps.2021.106078_bib0037","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1023\/A:1026143519395","article-title":"Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes","volume":"20","author":"Nasongkla","year":"2003","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.ejps.2021.106078_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081322","article-title":"The physicochemical, biopharmaceutical, and in vitro efficacy properties of freeze-dried dexamethasone-loaded lipomers","volume":"13","author":"Pena-Rodr\u00edguez","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejps.2021.106078_bib0039","first-page":"925","article-title":"Ocular delivery of ketorolac tromethamine using microemulsion as a vehicle: design, evaluation, and transcorneal permeation","volume":"24","author":"Salimi","year":"2020","journal-title":"J. Res. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2021.106078_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1208\/s12249-014-0257-x","article-title":"Effects of the preparation method on the formation of true nimodipine SBE-beta-CD\/HP-beta-CD inclusion complexes and their dissolution rates enhancement","volume":"16","author":"Semcheddine","year":"2015","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"12","key":"10.1016\/j.ejps.2021.106078_bib0041","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.xphs.2018.08.013","article-title":"In situ gel formulation for enhanced ocular delivery of nepafenac","volume":"107","author":"Shelley","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2021.106078_bib0042","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3928\/1081597X-20120210-01","article-title":"Vorinostat: a potent agent to prevent and treat laser-induced corneal haze","volume":"28","author":"Tandon","year":"2012","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.ejps.2021.106078_bib0043","doi-asserted-by":"crossref","DOI":"10.2174\/2211738509666210310160436","article-title":"Preparation and characterization of liposomes double loaded with amphotericin B and amphotericin B\/hydroxypropyl-beta-cyclodextrin inclusion complex","author":"Tran","year":"2021","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.ejps.2021.106078_bib0044","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpharm.2019.02.033","article-title":"Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate","volume":"562","author":"Wang","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"17","key":"10.1016\/j.ejps.2021.106078_bib0045","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1016\/j.bmc.2009.07.060","article-title":"Artemether\/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode","volume":"17","author":"Yang","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2021.106078_bib0046","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10717544.2019.1704941","article-title":"In vitro and in vivo evaluation of didymin cyclodextrin inclusion complexes: characterization and chemosensitization activity","volume":"27","author":"Yao","year":"2020","journal-title":"Drug. Deliv."},{"issue":"2","key":"10.1016\/j.ejps.2021.106078_bib0047","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2013.06.024","article-title":"Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification","volume":"453","author":"Ying","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejps.2021.106078_bib0048","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2008.0015","article-title":"Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits","volume":"24","author":"Zhang","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ejps.2021.106078_bib0049","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1139\/cjpp-2014-0117","article-title":"Suberoylanilide hydroxamic acid suppresses inflammation-induced neovascularization","volume":"92","author":"Zhou","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2021.106078_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejps.2017.08.020","article-title":"Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: in vitro characterization and in vivo permeation","volume":"109","author":"Zhou","year":"2017","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:04:59Z","timestamp":1760529899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":50,"alternative-id":["S0928098721003808"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.106078","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.106078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106078"}}